STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] Rocket Lab Corp SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Rocket Lab Corp (RKLB) filing a Form 144 notifies a proposed sale of 874,588 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $41,985,296.61. The filing states the shares were acquired on 09/18/2025 via previously exercised options and paid for in cash on the same date. The filer reports 479,355,713 shares outstanding for the issuer and lists an approximate sale date of 09/19/2025 on the NASDAQ. The filing indicates no securities sold by the account in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information.

Positive

  • None.

Negative

  • Proposed sale of 874,588 common shares for an aggregate market value of $41,985,296.61, which is a sizable insider transaction
  • The filing does not state a 10b5-1 plan adoption date or additional context about the reason for the sale

Insights

TL;DR: Insider plans to sell 874,588 shares valued at about $42M, acquired via option exercise the prior day; routine Form 144 disclosure.

The filing documents a proposed sale under Rule 144 of 874,588 shares acquired by previously exercised options on 09/18/2025. The broker is Morgan Stanley Smith Barney LLC and the sale is scheduled for 09/19/2025. The notice confirms payment in cash and that no sales were reported in the prior three months. From a regulatory perspective this is a standard disclosure required for restricted or control securities; it does not by itself disclose motives or company operational information.

TL;DR: Form 144 is procedural; it signals an insider transaction but provides no new company-specific operational details.

The form contains the mandatory attestations and a representation that the signer is unaware of undisclosed material adverse information. It identifies the method of acquisition (previously exercised options) and immediate planned sale via an institutional broker. This is consistent with compliance with Rule 144 and 10b5-1 considerations when applicable, but the filing does not include a trading-plan adoption date or additional contextual governance disclosures.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Rocket Lab's (RKLB) Form 144 disclose?

The Form 144 discloses a proposed sale of 874,588 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $41,985,296.61 and an approximate sale date of 09/19/2025.

How were the RKLB shares acquired that are being sold?

The shares were acquired on 09/18/2025 through previously exercised options and paid for in cash on that date.

How many Rocket Lab shares are outstanding according to the filing?

The filing reports 479,355,713 shares outstanding for the issuer.

Does the Form 144 report prior sales in the past three months for RKLB?

No; the filing states Nothing to Report for securities sold during the past three months by the person for whose account the securities are to be sold.

Who is the broker handling the proposed RKLB sale?

The broker named is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004.
Rocket Lab Usa Inc

NASDAQ:RKLB

RKLB Rankings

RKLB Latest News

RKLB Latest SEC Filings

RKLB Stock Data

22.67B
524.34M
1.77%
61.5%
12.35%
Aerospace & Defense
Guided Missiles & Space Vehicles & Parts
Link
United States
LONG BEACH